Lincomycin Injection, Solution
Product Images NDC 42571-374

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lincomycin (NDC 42571-374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lincomycin 10ml

Lincomycin 10ml
This is a description of Lincomycin Injection, USP, with a strength of 300 mg/10 in a 10 mL multiple-dose vial for intramuscular or intravenous use. It contains 300 mg/mL of lincomycin and 9.45 mg/mL of benzyl alcohol added as a preservative. It is manufactured by Micro Labs Limited in India and distributed by Micro Labs USA, Inc. in Somerset, NJ. The medication must be diluted before use if given intravenously, and dosage and usage instructions should be obtained from accompanying prescribing information. Store at controlled room temperature.*
FDA Label Image

Lincomycin 2ml

Lincomycin 2ml
Lincomycin Injection is used for intravenous or intramuscular treatment. It is only available through prescription and comes in a 2ml multiple-dose vial. It contains 600mg/2ml (300mg/mL) of lincomycin, and is manufactured by Micro Labs Limited. The medication must be diluted before use if given intravenously. Dosage information is available in the accompanying prescribing information. Store at controlled room temperature (20° to 25°C or 68° to 77°F) and it includes benzyl alcohol as a preservative.*
FDA Label Image

Strc (Lincomycin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.